Eiko Lifesciences informs about disclosure

03 Jun 2022 Evaluate

Eiko Lifesciences has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra (HUF).

The above information is a part of company’s filings submitted to BSE.

Eiko Lifesciences Share Price

53.96 -0.22 (-0.41%)
16-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3460.55
Tata Chemicals 657.95
SRF 2447.40
Pidilite Inds. 1354.20
Deepak Nitrite 1391.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×